Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Prognostic Score and Benefit from Abiraterone in First-line Metastatic, Castration-resistant Prostate CancerEur Urol 2021 Aug 06;[EPub Ahead of Print], D Lorente, C Llacer, R Lozano, G de Velasco, N Romero-Laorden, M Rodrigo, Á Sánchez-Iglesias, C di Capua, E Castro, C Ferrer, A Sánchez-Hernández, D Olmos
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.